Remove catalyst-connect
article thumbnail

The Catalyst Connect 2024 Survival Guide

PioneerRx

Catalyst Connect 2024 is rapidly approaching, where pharmacists and other healthcare professionals. It’s the most wonderful time of year for PioneerRx.

105
105
article thumbnail

The Catalyst Connect Survival Guide

PioneerRx

Catalyst Connect 2023 is rapidly approaching, where independent pharmacists and other healthcare. It’s the most wonderful time of year for PioneerRx.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Get Ready for Catalyst Connect 2023

PioneerRx

Catalyst Connect 2023 is mere days away and this year’s event is shaping up to be the most. Time flies when you’re having fun. But the fun is only beginning.

52
article thumbnail

On the Go: Pharmacy Solutions for Summer Travel Medications

PioneerRx

From getting ready for graduation ceremonies to preparing for your favorite user conference (hello, Catalyst Connect 2024). The summer is rapidly approaching.

105
105
article thumbnail

Early Bird Gets the (Pharmacy) Worm: Register for Catalyst Connect 2024

PioneerRx

The new year is not so new anymore, the ice is thawing, and the almighty groundhog declares that an early spring is around the corner. Though spring is slowly.

52
article thumbnail

CGT Catapult to bolster new UK life sciences campus

European Pharmaceutical Review

The facility houses 12 segregated independent Good Manufacturing Practice (GMP) cleanroom modules and offers international connectivity and supply chain links. The CGT Catapult established its 7,700m 2 Medicines and Healthcare products Regulatory Agency (MHRA) licensed Manufacturing Innovation Centre (MIC) in Stevenage in 2018.

89
article thumbnail

Magenta Therapeutics Entered into a Definitive Merger Agreement with Dianthus Therapeutics to Advance DNTH103 for Severe Autoimmune Diseases

PharmaShots

The transaction is expected to close in Q3’23 The funding will support DNTH103 through multiple clinical data catalysts incl. For more information connect with us at connect@pharmashots.com P-I trial in healthy volunteers & P-II trials in gMG & other indications (expected to initiate in Q1’24).

40